title: Building data quality into clinical trials.
abstract: Meaningful data begin with the collection process. Pharmaceutical companies are using several different strategies in clinical trials to ensure the highest quality of data. This article will examine these approaches, with an emphasis on case report form development through database release.
authors.affiliation: Pfizer, Inc., USA.
authors.forename: William J
authors.initials: WJ
authors.lastname: Crerand
authors.forename: Jana
authors.initials: J
authors.lastname: Lamb
authors.forename: Vera
authors.initials: V
authors.lastname: Rulon
authors.forename: Bilun
authors.initials: B
authors.lastname: Karal
authors.forename: Jack
authors.initials: J
authors.lastname: Mardekian
mesh_terms: D000043:Abstracting and Indexing; D002985:Clinical Protocols; D002986:Clinical Trials as Topic / Q000592:standards*; D003625:Data Collection / Q000592:standards; D003628:Database Management Systems / Q000592:standards*; D004341:Drug Evaluation; D004345:Drug Industry / Q000458:organization & administration* / Q000592:standards; D004496:Education, Continuing; D005568:Forms and Records Control / Q000592:standards*; D006801:Humans; D010355:Patient Identification Systems; D011786:Quality Control; D012107:Research Design / Q000592:standards; D014481:United States